logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8569281 B1

PDFFull Text
Expired
Date of Patent:
Oct. 29, 2013

Filed:

Sep. 21, 2011

Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as lrrk

Applicants:

Bryan K. Chan, South San Francisco, CA (US);

Huifen Chen, South San Francisco, CA (US);

Anthony Estrada, South San Francisco, CA (US);

Daniel Shore, South San Francisco, CA (US);

Zachary Sweeney, Emeryville, CA (US);

Edward Giles Mciver, London, GB;

Inventors:

Bryan K. Chan, South San Francisco, CA (US);

Huifen Chen, South San Francisco, CA (US);

Anthony Estrada, South San Francisco, CA (US);

Daniel Shore, South San Francisco, CA (US);

Zachary Sweeney, Emeryville, CA (US);

Edward Giles McIver, London, GB;

Assignees:

Medical Research Council Technology, London, GB;

Genentech, Inc., South San Francisco, CA (US);

Attorneys:

Nelson Mullins Riley & Scarborough LLP

Cynthia L. Kanik

Primary Examiner:

Raymond Henley, Iii

Int. Cl.
CPC ...
A61K 31/5365 (2006.01); A61K 31/00 (2006.01); A61K 31/44 (2006.01); C07D 498/00 (2006.01); C07D 413/00 (2006.01); C07D 401/00 (2006.01); C07D 471/02 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to substituted pyrazolopyridine compounds, and pharmaceutically acceptable salts or esters thereof. The present invention further relates to therapeutic uses of pharmaceutical compositions comprising the substituted pyrazolopyridine compounds, for example, in cancer and neurodegenerative diseases.

Find Patent Forward Citations

Quick Actions:

Chan, Bryan. (2013). Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as lrrk (U.S. Patent No. 8569281). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8569281

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…